Rituximab for double-positive anti-GBM antibody and ANCA-associated glomerulonephritis: The first reported case in Asia and literature review
Clinical Nephrology · 2025
DOI: 10.5414/cn111588 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Nephrology, 2025. Verfasst von Chang-Ying Chen und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Anti-Glomerular Basement Membrane Disease, Antibodies, Antineutrophil Cytoplasmic, Glomerulonephritis, Rituximab. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Chen, C. Y., Chen, Y. R., Lin, W. R., & Lin, W. H. (2025). Rituximab for double-positive anti-GBM antibody and ANCA-associated glomerulonephritis: The first reported case in Asia and literature review. Clinical Nephrology. https://doi.org/10.5414/cn111588
Vancouver
Chen CY, Chen YR, Lin WR, Lin WH. Rituximab for double-positive anti-GBM antibody and ANCA-associated glomerulonephritis: The first reported case in Asia and literature review. Clinical Nephrology. 2025. doi:10.5414/cn111588
BibTeX
@article{Chen2025,
author = {Chen, Chang-Ying and Chen, Ying-Ren and Lin, Wei-Ren and Lin, Wei-Hung},
title = {Rituximab for double-positive anti-GBM antibody and ANCA-associated glomerulonephritis: The first reported case in Asia and literature review},
journal = {Clinical Nephrology},
year = {2025},
doi = {10.5414/cn111588}
}
EUVIMED